Management of Scalp Skin Lesions
For suspicious scalp lesions, perform complete excisional biopsy with a 2 mm margin of normal skin using a scalpel under local anesthesia, rather than partial biopsy or tissue-destructive methods, to enable accurate histopathological diagnosis and assessment of prognostic factors. 1
Initial Clinical Assessment
Examination Technique
- Examine the entire scalp systematically, as scalp lesions are frequently missed during routine dermatological consultations due to hair coverage 1, 2
- The scalp requires careful inspection as it harbors approximately 2% of all cutaneous neoplasms, with worse prognosis compared to other anatomical sites 2
Clinical Criteria for Malignancy Suspicion
Evaluate pigmented lesions using the ABCDE criteria 1:
- A: Asymmetry
- B: Irregular borders
- C: Heterogeneous color
- D: Large diameter (>7 mm)
- E: Evolution (recent change in size, color, or shape)
Additional concerning features include hypersensitivity, bleeding, and inflammation 1
Dermoscopy Considerations
- Dermoscopy can improve diagnostic accuracy for pigmented lesions and differentiate melanocytic from non-melanocytic lesions (seborrheic keratosis, pigmented basal cell carcinoma, hemangioma) 1
- Should only be used by experienced practitioners and is not recommended as routine practice 1
- For tinea capitis, dermoscopy can visualize black dot hair stubs and comma-shaped hairs more clearly 1
Diagnostic Sampling Strategy
For Suspected Malignant Lesions
Complete excisional biopsy is mandatory rather than partial biopsy for the following critical reasons 1:
- Eliminates need for further treatment if benign
- Prevents misdiagnosis from partial examination
- Allows assessment of all histological parameters, particularly maximum Breslow thickness
- Enables accurate margin clearance determination
Excision Technique
- Use a scalpel with 2 mm margin of normal skin under local anesthesia 1
- Create elliptical incision with long axis parallel to skin lines to facilitate potential re-excision with minimal skin loss 1
- Never use laser or electro-coagulation, as tissue destruction compromises diagnosis and prognostic assessment 1
- Document excision margins in the operation note 1
- Avoid frozen sections 1
For Suspected Fungal Infections (Tinea Capitis)
Multiple sampling methods increase diagnostic yield 1:
- Pluck affected hairs (especially those fluorescing under Wood's lamp for Microsporum canis) 1
- Blunt scalpel scraping to remove hair and scalp scale 1, 3
- Cytobrush sampling improves sensitivity and time to positive culture, though prevents microscopic examination 1
- Gauze swabs provide equally effective and convenient alternative 1
- Store specimens in paper or card packs 1
Laboratory Processing
For Suspected Malignancy
Histopathological report must include 1:
- Diagnosis confirming melanocytic nature and malignancy
- Maximum tumor thickness in millimeters (Breslow method)
- Assessment of complete excision of invasive and in situ components
- Microscopic measurement of shortest clearance extent
- Clark level of invasion
- Presence and extent of regression
- Presence and extent of ulceration
For Suspected Fungal Infection
- Mount specimens in 10-30% potassium hydroxide with or without calcofluor for microscopy 1, 3
- Culture on Sabouraud agar with cycloheximide, incubated for at least 2 weeks 1, 3
- For suspected Trichophyton verrucosum (cattle exposure), incubate up to 3 weeks 1
- Antifungal susceptibility testing is not routinely indicated 1
Treatment by Lesion Type
Actinic Keratosis on Scalp
Imiquimod 5% cream is first-line topical therapy for clinically typical, non-hyperkeratotic, non-hypertrophic actinic keratoses in immunocompetent adults 1, 4:
- Apply 2 times per week for 16 weeks to defined 25 cm² treatment area 4
- Apply before sleep, leave for 8 hours, then wash with mild soap and water 4
- Achieves 50% complete clearance rate in randomized controlled trials 1
- 46% and 44% complete clearance in two large studies versus 3-4% with vehicle 4
Alternative options 1:
- 5-Fluorouracil 0.5% in 10% salicylic acid: 55.4% complete clearance versus 15.1% with vehicle
- Photodynamic therapy: 88-100% clearance at 3 months, with 68-89% remaining clear at 17-50 months 1
- Cryotherapy: Appropriate for individual lesions
Squamous Cell Carcinoma In Situ (Bowen's Disease)
- Photodynamic therapy with MAL: 88-100% clearance at 3 months 1
- Radiotherapy: Effective but avoid on lower legs due to poor healing; can be used on scalp 1
- CO₂ laser: Limited evidence, considered for challenging sites 1
Tinea Capitis
Oral antifungal therapy is required for eradication 1:
- Itraconazole 100 mg daily: 87% mycological cure rate (superior to griseofulvin's 57%) 3
- Terbinafine: Superior for Trichophyton tonsurans infections 3
- Treatment endpoint should be mycological cure, not just clinical response 3
- Continue until mycological clearance documented with repeat sampling 3
Prevention measures 3:
- Cover lesions to prevent spread
- Keep affected areas clean and dry
- Screen and treat family members for anthropophilic species
Common Pitfalls to Avoid
Diagnostic Errors
- Never perform partial biopsy of suspected melanocytic lesions—risk of misdiagnosis and inability to assess Breslow thickness 1
- Avoid tissue-destructive methods (laser, electrocautery) that compromise histological assessment 1
- Do not rely on clinical improvement alone for fungal infections—confirm mycological cure 3
Treatment Errors
- Do not stop antifungal treatment early based only on clinical improvement rather than mycological cure 3
- Do not extend imiquimod treatment beyond 16 weeks due to missed doses or rest periods 4
- Consider secondary bacterial infection in inflammatory cases 3
- Do not use radiotherapy on lower leg lesions due to poor healing (33% failure rate) 1
Follow-up Considerations
- Lesions not responding to standard treatment require re-evaluation and possible excision to rule out invasive squamous cell carcinoma 1
- For actinic keratosis, response cannot be adequately assessed until local skin reactions resolve 4
- Patients with ≥10 actinic keratoses have threefold higher risk of squamous cell carcinoma and warrant closer surveillance 1